PERK inhibition attenuates vascular remodeling in pulmonary arterial hypertension caused by BMPR2 mutation
暂无分享,去创建一个
Y. Urade | Y. Kanki | T. Kawamura | Y. Wada | Yoshiki Higashijima | R. Nakaki | Takashi Shimizu | Ryo Nakaki
暂无分享,去创建一个
Y. Urade | Y. Kanki | T. Kawamura | Y. Wada | Yoshiki Higashijima | R. Nakaki | Takashi Shimizu | Ryo Nakaki